Explore the detailed record of transactions filed by Violin Jonathan, Director. Director active across 2 companies, notably Astria Therapeutics, Inc.. Cumulatively, 10 filings have been logged. Total volume traded: €2.1m. The latest transaction was disclosed on 1 June 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Jonathan Violin is the President and Director at Astria Therapeutics, Inc. and Viridian Therapeutics, Inc. He plays a key role in the strategic direction of these companies, overseeing operations and the development of new products. Jonathan contributes to guiding research and development initiatives.